Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B.

Journal of hepatology - 1 Feb 2013

Micco Lorenzo, Peppa Dimitra, Loggi Elisabetta, Schurich Anna, Jefferson Lucy, Cursaro Carmela, Panno Arianna Martello, Bernardi Mauro, Brander Christian, Bihl Florian, Andreone Pietro, Maini Mala K

Abstract excerpt

BACKGROUND & AIMS: A better understanding of the immunomodulatory effects of PegIFNα therapy could allow more rational optimisation of future therapeutic approaches in chronic HBV infection. In this study, we evaluated dynamic changes in the innate and adaptive arms of the immune system induced b...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adaptive Immunity
Share to CD56 Antigen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CD8-Positive T-Lymphocytes

Share to Hepatitis B, Chronic

Share to Interferon-alpha

Share to Interleukin-15

Share to Killer Cells, Natural

Share to Polyethylene Glycols

Source

Identifiers

PMID: 23046671
DOI: 10.1016/j.jhep.2012.09.029

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23046671-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B.PMID 23046671Read ↗

Pegylated Interferon α-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg Seroconversion.Semantic proximity Read ↗

NK cell phenotypic and functional shifts coincide with specific clinical phases in the natural history of chronic HBV infection.Semantic proximity Read ↗

Expanded adaptive NKG2C+ NK cells exhibit potent ADCC and functional responses against HBV-infected hepatoma cell linesSemantic proximity Read ↗

Early kinetics of innate and adaptive immune responses during hepatitis B virus infection.Semantic proximity Read ↗

CD8 T cells with classical and NK-like cytotoxic gene expression programs mediate control of HBV replication and functional cureSemantic proximity Read ↗

Enhanced functions of peripheral γδ T cells in chronic hepatitis B infection during interferon α treatment in vivo and in vitro.Semantic proximity Read ↗

Early interferon therapy for hepatitis C virus infection rescues polyfunctional, long-lived CD8+ memory T cells.Semantic proximity Read ↗

Changes of natural killer cells' phenotype in patients with chronic hepatitis B in intermittent interferon therapy.Semantic proximity Read ↗

Interferon Therapy of Chronic Hepatitis BSemantic proximity Read ↗

Chronic HCV infection affects the NK cell phenotype in the blood more than in the liver.Semantic proximity Read ↗

Peripheral NK cell phenotypic alteration and dysfunctional state post hepatitis B subviral particles stimulation in CHB patients: evading immune surveillance.Semantic proximity Read ↗

Chronic genotype 1 hepatitis C along with cirrhosis drives a persistent imprint in virus-specific CD8+ T cells after direct-acting antiviral therapies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.